We are live on ! Find out more
GBIO

Generation Bio
GBIO

Delisted

GBIO was delisted on the 6th of February, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of GBIO yet.

GBIO Hedge Fund Activity: Q1 2026 in Review

2 of the 8,159 institutional investors tracked by Wall St. Rank reported a position in Generation Bio (GBIO) for Q1 2026, worth a combined $53.3K — down 100% from $24.5M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of GBIO and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Accent Capital Management, adding an estimated $195. The largest seller was Atlas Venture Life Science Advisors, exiting entirely with an estimated $4.7M sold.

  • 2 institutional investors held Generation Bio (GBIO) as of Q1 2026, down from 48 in Q4 2025.
  • Funds reported $53.3K of Generation Bio stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Generation Bio positions in Q1 2026 and 45 closed out, a net change of -45 holders.
  • The largest Generation Bio buyer in Q1 2026 was Accent Capital Management, an estimated $195 added.
  • The largest Generation Bio seller in Q1 2026 was Atlas Venture Life Science Advisors, an estimated $4.7M sold.

Based on aggregated 13F filings for Q1 2026.